Delivery Order SPE2DB22D2206-SPE2DB24FJE76

Award Date 7/15/24
Potential Completion Date 8/5/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,424.08 firm fixed-price delivery order is for the supply of Talzenna 0.5 mg capsules. The contract has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,493.82, is for the delivery of TALZENNA 0.5 MG SOFTGEL 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $10,424.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of the prescription drug Talzenna 1 mg capsule and does not have a set-aside designation. Amerisourcebergen, a subsidiary of the Amerisourcebergen Corporation, has extensive experience providing a wide range of medications and medical supplies to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $10,784.34 with a completion date of February 4, 2025. It is for the supply of Talzenna 0.5 mg Capsule 30s, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,246.91, is a delivery order for the supply of a specific pharmaceutical product, Talzenna 0.5 mg softgel 30s. The contract is a firm fixed-price, non-set-aside arrangement with a completion date of May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of TALZENNA 0.25 MG CAPSULE 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $10,040.85, has a completion date of February 12, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product to the DLA Troop Support Medical facility located in Conshohocken, Pennsylvania. This award...
This federal contract award is a delivery order valued at $4,817.16 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of JATENZO 237 MG CAPSULE 120S, a medical product, with a completion date of December 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of pharmaceutical products and medical supplies, including the prescription drug Tagrisso, to the Defense Logistics Agency (DLA). The award is a Delivery Order under a $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of medical commodities...
This federal contract award, valued at $2,188.14, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp Corporate Office Division. The award is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. The contract has a firm fixed price and the ultimate completion date is August 15, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,451.13 firm fixed price delivery order is for the supply of XELJANZ 10 MG tablet pharmaceuticals. The contract has an ultimate completion date of February 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJE76
    Delivery Order

This federal contract award, valued at $10,424.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TALZENNA 1 MG CAPSULE 30S pharmaceutical product.

Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This specific contract award does not have a set-aside designation and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market. The contract has an ultimate completion date of August 5, 2024.

Generated 10/14/24, 10:13 AM